N/A
N=26
Tandem VR: Synchronized Nature-Based Experiences in Virtual Reality for Hospice Patients and Their Caregivers
Hospice · End of Life · Palliative Care · Pain · Anxiety
Bottom Line
View on ClinicalTrials.gov: NCT06186960 ↗Enrolled (actual)
26
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Quality of Life Domains — 1.68; 1.27 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Tandem Virtual Reality (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Prisma Health-Upstate
- Primary completion
- Nov 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Life Domains |
1.68; 1.27 | — |
| PRIMARY Fear of Death |
-0.04; 0.50; -0.31; -0.11; 0.00; 0.50 | — |
| PRIMARY Perception of Pain |
-0.64; -0.18 | — |
| PRIMARY Acceptance of Tandem VR |
22 | — |
| PRIMARY Perceived Benefits and Value of Tandem VR |
22; 4; 8 | — |
Summary
Background: Nature-based virtual reality (VR) and other outdoor experiences in head-mounted displays (HMDs) offer powerful, non-pharmacological tools for hospice teams to help patients undergoing end-of-life (EOL) transitions. However, the psychological distress of the patient-caregiver dyad is interconnected and highlights the interdependence and responsiveness to distress as a unit. Hospice care services and healthcare need strategies to help patients and informal caregivers with EOL transitions.
Eligibility Criteria
Inclusion criteria
- English speaking
- Projected life expectancy of <6 months (established by hospice experts)
- Cognitively intact (has sufficient judgment, planning, organization, and self-control)
Exclusion criteria
- Having a cognitive impairment that affects protocol participation. This will be done with the assistance of Research Recruiters to assess eligibility.
- Have a condition that interferes with VR usage, including but not limited to seizures, facial injury precluding safe placement of headset
- Have a prognosis of hours or actively dying at the time enrollment
- Patients with motion sickness
- Patients with claustrophobia
- Patients with visual and hearing impairment
- Patients with inability to speak English
Data sourced from ClinicalTrials.gov (NCT06186960). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.